Group 1: Market Sentiment and Options Activity - Deep-pocketed investors have adopted a bullish approach towards Eli Lilly, indicating potential significant developments ahead [1] - Benzinga's options scanner highlighted 39 extraordinary options activities for Eli Lilly, with 35% of investors leaning bullish and 35% bearish [2] - The total volume of notable options includes 11 puts totaling $545,137 and 28 calls amounting to $3,038,945 [2] Group 2: Price Predictions and Trading Trends - Big players are eyeing a price range from $550.0 to $1100.0 for Eli Lilly over the past quarter [3] - Volume and open interest trends provide insights into liquidity and interest levels for Eli Lilly's options at specific strike prices [4] Group 3: Current Market Status and Analyst Opinions - Eli Lilly's current market status shows an average target price of $1118.8 from 5 industry analysts [10] - Analysts from various firms have differing ratings and target prices, with JP Morgan at $1150, Freedom Capital Markets at $950, Leerink Partners at $1104, Morgan Stanley at $1290, and BMO Capital at $1100 [11] Group 4: Company Overview - Eli Lilly focuses on neuroscience, cardiometabolic, cancer, and immunology, with key products including Verzenio, Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, Humulin, Taltz, and Olumiant [9]

Benzinga's options scanner has just identified more than 9 option transactions on SentinelOne (NYSE:S), with a cumulative value of $1,802,784. Concurrently, our algorithms picked up 2 puts, worth a total of 78,430.Expected Price MovementsBased on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $13.0 to $25.0 for SentinelOne over the recent three months. Insights into Volume & Open InterestLooking at the volume and open interest is a powerful m ...

Time now for Options Corner. Joining us to take a deeper look at this chart is Rick Dukat, lead market technician here on Schwab Network. All right.Uh Rick, so many say that Broadcom should be a member of the MAG 7 and especially if you look at its performance year to Jade. So what are the trends that you notice when you take a look at this chart. >> Hey, just looking at market cap, Broadcom is now number seven.Uh it's above uh uh Tesla and Meta and Birkshshire Hathway in terms of market cap. So pretty prac ...

Aerospace & defense stock RTX Corp (RTX) is posing an attractive entry point for options bulls right now. The shares have pulled back from their Oct. 28 record high of $181.34, last seen up 1.9% to trade at $171.59 today. However, the recent drawdown is testing a key technical level on the charts, one with bullish quantitative history.Per Schaeffer's Senior Quantitative Analyst Rocky White, RTX is within 0.75 of the 80-day moving average's 20-day average true range (ATR), after remaining above it 80% of the ...

investing to take a closer look at Amazon, how it's being traded today and some of the options activity that we might be seeing. Alex, you know, as we take a look at this story, it's tough to note, you know, whether or not it will be of of meaningful impact to the stock price until we get some actual details here, but we are seeing a move, you know, about a percent and a half to the downside, but we are also seeing a down market today. Yeah, I think when it comes to this, what we found in the past when I be ...

Core Insights - Deep-pocketed investors are adopting a bearish approach towards Celsius Holdings, indicating potential significant market movements ahead [1] - The sentiment among heavyweight investors is mixed, with 62% bearish and 25% bullish, highlighting a notable options activity [2] - Major market movers are focusing on a price range between $36.0 and $60.0 for Celsius Holdings over the last three months [3] Options Activity - In the last 30 days, there has been extraordinary options activity for Celsius Holdings, with a total of $266,512 in puts and $232,393 in calls [2] - The biggest options trades include a bullish put sweep with a total trade price of $149.3K at a strike price of $44.00 and a bearish put sweep at a strike price of $37.50 totaling $65.8K [8] Company Overview - Celsius Holdings operates in the energy drink segment of the global nonalcoholic beverage market, with 95% of its revenue generated in North America [9] - The company owns three energy drink brands: Celsius, Alani Nu, and Rockstar Energy, focusing on product innovation and marketing while outsourcing manufacturing and distribution [9] Market Position - Analysts have issued ratings for Celsius Holdings, with a consensus target price of $61.6, reflecting a generally positive outlook despite mixed investor sentiment [11] - Specific analyst ratings include a Buy from Citigroup with a target of $65, an Overweight from JP Morgan at $68, and a Buy from Stifel at $60, while B of A Securities maintains an Underperform rating with a target of $50 [12]

Core Viewpoint - Investors are showing a bullish stance on Lululemon Athletica, indicated by significant options trading activity, suggesting that there may be upcoming developments that could impact the stock price [1][2]. Options Trading Activity - Benzinga's options scanner identified 29 uncommon options trades for Lululemon Athletica, with a split sentiment among big-money traders: 41% bullish and 41% bearish [2][3]. - The total amount for put options was $1,085,113, while call options totaled $1,437,728, indicating a notable interest in both directions [3]. Price Projections - The analysis of volume and open interest suggests that major players are targeting a price range for Lululemon Athletica between $150.0 and $300.0 over the past quarter [4]. Volume and Open Interest Trends - Insights into volume and open interest are crucial for understanding liquidity and interest levels in Lululemon Athletica's options, particularly within the strike price range of $150.0 to $300.0 over the past month [5]. Largest Options Trades - Significant options trades include: - A call trade with a total price of $460,000 at a strike price of $220.00, expiring on 09/18/26 [9]. - A put trade valued at $363,300 with a strike price of $175.00, expiring on 12/19/25 [9]. - Additional bearish call trades with varying strike prices and sentiments, indicating mixed market expectations [9]. Current Market Status - Lululemon Athletica has a consensus target price of $222.0 from three market experts, with individual ratings reflecting a range of sentiments from Neutral to Buy [12][13]. - Trading volume for Lululemon Athletica stands at 1,808,405, with the stock price at $182.71, showing a slight increase of 0.22% [15].

Core Insights - The options trading on Wednesday highlighted significant activity, particularly in Alcoa's $40 put option and Celsius Holdings' call options, indicating investor interest and potential volatility in these stocks [1][2]. Group 1: Options Trading Activity - A total of 1,222 unusually active options were traded, with Alcoa's Dec. 12 $40 put having a Vol/OI ratio of 93.69, making it the most notable option [1]. - Celsius Holdings (CELH) saw two call options with Vol/OI ratios exceeding 25, reflecting a split sentiment among investors regarding the stock's future price [2][3]. Group 2: Celsius Holdings Stock Performance - CELH stock has experienced a 29% decline over the past month following the announcement of its Q3 2025 financial results, yet it remains up 59% year-to-date in 2025 [1]. - The current debate among investors revolves around the stock's potential valuation, with estimates ranging from $25 to $65 [2]. Group 3: Call Options Strategies - The two active call options for CELH attracted interest from both small and large investors, with varying trade sizes indicating diverse strategies being employed [4]. - Suggested strategies for trading these call options include Bull Call Spread, Bear Call Spread, and Ratio Call Spread, each catering to different market outlooks [4][5]. Group 4: Bull Call Spread Details - A Bull Call Spread is recommended for moderately bullish investors, utilizing the premium income from a short call to offset the cost of a long call [5][6]. - The analysis suggests a preference for the $48 strike price due to its higher profit potential compared to other options, despite a slightly higher cost [7].

Group 1 - Deep-pocketed investors are showing a bullish sentiment towards Caterpillar, indicating potential significant developments ahead [1] - Recent options activity for Caterpillar has been unusually high, with 68 notable options trades observed, where 51% are bullish and 27% bearish [2] - The price target for Caterpillar is being eyed between $300.0 and $790.0 based on the volume and open interest of options contracts [3] Group 2 - The average open interest for Caterpillar options is 597.26, with a total trading volume of 15,021.00, reflecting a robust trading environment [4] - A snapshot of the options trading reveals a mix of bullish and neutral sentiments, with significant call options activity noted [8] - Caterpillar is a leading manufacturer in construction and mining equipment, with a market share approaching 20% across various products and a global operational reach [10] Group 3 - Recent expert opinions suggest an average target price of $667.5 for Caterpillar, with mixed ratings from analysts [12] - An analyst from Wells Fargo has lowered its rating to Overweight with a new price target of $675, while HSBC upgraded its rating to Buy with a target of $660 [13] - The current stock price of CAT is $591.26, reflecting a slight decrease of -0.04% [15]

Core Insights - Financial giants are showing a bearish sentiment towards Regeneron Pharmaceuticals, with 50% of traders indicating bearish tendencies and only 33% being bullish [1] - The trading activity suggests a focus on a price range between $500.0 and $750.0 for Regeneron Pharmaceuticals over the past three months [2] - Recent options activity indicates a mix of bullish, neutral, and bearish sentiments among traders, with significant put trades observed [8] Options Activity - A total of 12 unusual trades were identified, with 7 puts valued at $790,722 and 5 calls valued at $142,680 [1] - The volume and open interest data for Regeneron Pharmaceuticals' options provide insights into liquidity and trader interest within the $500.0 to $750.0 strike price range over the last 30 days [3] - Noteworthy options activity includes various trades with different sentiments, including bullish, neutral, and bearish positions, across multiple expiration dates and strike prices [8] Market Status - Regeneron Pharmaceuticals has a consensus target price of $787.4 from 5 market experts, with individual ratings ranging from $660 to $890 [10][11] - The current market price of REGN is $731.99, reflecting a 1.15% increase, with upcoming earnings expected in 61 days [13]